Overview

Allopurinol Add-on Treatment for Refractory Mania

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of allopurinol as an augmentation agent for treatment resistant mania and mixed mania.
Phase:
Phase 4
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Treatments:
Allopurinol